BERLIN, GERMANY — At Mary Jane Berlin, one of the biggest themes wasn't simply new genetics—it was the globalization of premium breeding. For years, Seed Junky has helped define modern cannabis through award-winning cultivars like Permanent Marker, Animal Face, Kush Mints, and dozens of elite selections that have become staples across North America. Now, the California breeding powerhouse is making its most significant push into Europe through a strategic partnership with Yuval Soiref's Green Success Group and the newly launched ZAZA platform.

sSpeaking with Honeysuckle Magazine at Messe Berlin, Seed Junky founder JBeezy, partner Wes Vasquez, and Green Success founder Yuval Soiref described a collaboration built on much more than licensing genetics. Their vision centers on quality control, patient access, education, and bringing authentic California breeding standards into Europe's rapidly expanding medical market.

For JBeezy, the mission has remained remarkably consistent since the beginning.

"My original vision was just to spread the dank across the world," he explained. "Provide the best genetics to growers because when I first started, nobody would give me a clone. Once I finally got my hands on the fire, I wanted to make sure growers—and ultimately patients and consumers—could always access high-quality flower."

That philosophy still drives Seed Junky's breeding process today.

Rather than chasing trends, the company hunts through thousands of seedlings before selecting only a handful worthy of release. Flavor remains king, but potency, cultivation performance, yield, structure, terpene expression, and consistency all play equally important roles.

"We're looking for everything from A to Z," JBeezy said. "Flavor is incredibly important, but it has to check every box. The effects have to be accurate. If we say something helps you work out or relax, we want that to actually be true."

Instead of relying solely on personal preference, Seed Junky combines laboratory testing with blind internal evaluations, repeatedly sampling cultivars before making final selections.

"It's not only about me," JBeezy said. "We survey our whole team because different perspectives matter."

That obsessive selection process has produced some of the industry's most recognizable genetics, but according to partner Wes Vasquez, breeding is only one piece of the equation.

"We've evolved from simply finding incredible plants to bringing those selections into as many legal markets as possible," Vasquez explained. "We believe we have the best genetics in the world, but it's JB's ability to identify the keeper phenotypes that separates Seed Junky."

Rather than acting solely as breeders, Seed Junky operates cultivation facilities, manages large-scale production, oversees branding, marketing, and distribution, while working directly with cultivation partners to maintain consistency.

"We're operators," JBeezy said. "We cultivate it, package it, distribute it, build the brand, and support our partners every step of the way."

That operational mindset is precisely what attracted Green Success.

Soiref described the relationship as years in the making, built on mutual respect and shared standards rather than a quick licensing deal.

"Working with JB closes a cycle and begins a new movement for medical cannabis," Soiref said. "It's not just about entrepreneurs—it's about patients."

He believes Europe requires more than famous genetics. It requires regulatory compliance, education, and systems capable of delivering consistent medicine.

"The professionalism is second to none," Soiref said. "Only genetics that are fully tested make it through. Europe has different regulations than America, and that's exactly why this partnership works."

Central to that strategy is ZAZA, Green Success's new patient platform designed to become a home for premium international brands entering Europe's regulated market.

"ZAZA is the home of the brands," Soiref explained. "The patient needs access to ZAZA. We focus on patient access, patient education, consistency, and bringing the best genetics together under one house."

The partnership reflects the rapid evolution of Europe's medical sector, particularly Germany, where demand for premium genetics continues to accelerate following regulatory reforms.

While many consumers recognize Seed Junky for headline strains like Permanent Marker, JBeezy says every release begins with painstaking research.

Current favorites include Caffeine, which he describes as combining exceptional terpene production with functional daytime effects, while upcoming releases like Mango Fruz, LA Pop Rocks, and collaborations with Green Success are already moving through the pipeline.

Consistency, however, remains the hardest challenge.

"The same product has to exist in multiple states and countries," JBeezy explained. "We're constantly working with our partners on SOPs, irrigation, drying, quality control—everything. You can't just hand someone a clone and hope it turns out right."

For Vasquez, expanding internationally means carrying that same philosophy across continents.

"This industry is one of the hardest in the world to standardize," he said. "Our commitment is bringing the same experience to every market."

Mary Jane Berlin also reinforced something both founders found refreshing about Europe's emerging market.

"The German market really appreciates quality," JBeezy observed. "People here have a passion for the plant. They're looking for great flavor, great flower, and they want authentic California-quality genetics."

By the close of the interview, Seed Junky outlined an ambitious roadmap extending from California across the United States and into Germany, the United Kingdom, and additional European markets through Green Success and ZAZA.

As Europe's medical market continues to mature, the partnership signals more than an international expansion. It reflects a growing convergence between California's culture of elite breeding and Europe's increasingly sophisticated pharmaceutical infrastructure—one where premium genetics, patient education, and rigorous cultivation standards are becoming part of the same conversation.